Date	Period	Revenue/Estimate	Earnings Call
--	2024/H2	-- / 536.589M	--
Aug 28, 2024	2024/H1	410.499M / 410.208M	--
Mar 27, 2024	2023/H2	390.076M / 367.732M	--
Aug 28, 2023	2023/H1	326.836M / 313.852M	--
Mar 27, 2023	2022/H2	304.750M / 347.693M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/H2-- / 536.589M--

Aug 28, 20242024/H1410.499M / 410.208M--

Mar 27, 20242023/H2390.076M / 367.732M--

Aug 28, 20232023/H1326.836M / 313.852M--

Mar 27, 20232022/H2304.750M / 347.693M--

Unlock Free Earnings Estimates

Open Account

BIOCYTOGEN-B: POSITIVE PROFIT ALERT

Jan 27 03:41 ET

BIOCYTOGEN-B: 2024 Interim Report

Sep 25, 2024 04:45 ET

BIOCYTOGEN-B: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 28, 2024 07:46 ET

BIOCYTOGEN-B: DATE OF BOARD MEETING

Aug 16, 2024 04:33 ET

02315 BIOCYTOGEN-B

BIOCYTOGEN-B Key Stats